News Focus
News Focus
icon url

sox040713

01/15/18 9:02 PM

#212956 RE: scottsmith #212954

I suggest you to read this post by PlentyParanoid.

DO not put much value on the 96 % reduction in duration. Calculated in similar manner Brilacidin had duration reduction of 100 %. Those numbers are based on medians and are, by their lonesome, utterly, frivolously useless.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137692344



So B-OM is better? That’s a ‘shock’. Good luck trying to get insurance to reimburse IV treatments for seven weeks when the alternative is an oral rinse.
icon url

williamssc

01/15/18 9:08 PM

#212958 RE: scottsmith #212954

We have a drug who's full potential hasn't even scratched the surface yet. B's potential is huge just like the deal were getting. B in the right oral formulation could end OM.